RLAY Latest Headlines

Near the top of biotech rankings, AbbVie's Q1 beat makes a case for more upside

at seekingalpha.com (Wed, 29-Apr 10:41 AM)

Analysts Offer Insights on Healthcare Companies: Fulcrum Therapeutics (FULC) and Relay Therapeutics (RLAY)

at www.tipranks.com (Tue, 28-Apr 8:10 AM)

Barclays Reaffirms Their Buy Rating on Relay Therapeutics (RLAY)

at www.tipranks.com (Tue, 28-Apr 5:18 AM)

Analyst Reiterates Buy on Relay Therapeutics, Citing Promising Zovega mBC Data, Favorable Safety Profile, and Phase 3 First-Line Breast Cancer Upside

at www.tipranks.com (Tue, 28-Apr 5:15 AM)

Roundhill META WeeklyPay ETF announces weekly distribution of $0.3071

at seekingalpha.com (Mon, 27-Apr 1:34 PM)

Analysts Offer Insights on Healthcare Companies: Cormedix (CRMD) and Relay Therapeutics (RLAY)

at www.tipranks.com (Mon, 27-Apr 12:40 PM)

Relay Therapeutics advances zovegalisib combo in breast cancer

at www.tipranks.com (Mon, 27-Apr 9:47 AM)

Relay Therapeutics Highlights Strong Efficacy and Tolerability for Zovegalisib at Phase 3 Dose in PI3Ka-Mutant Breast Cancer

Market Chameleon (Mon, 16-Mar 7:53 AM)

Relay Therapeutics Poised for Impact as Biliary Tract Cancer Market Set for 10.1% CAGR Growth Through 2034

Market Chameleon (Tue, 3-Mar 7:42 AM)

Relay Therapeutics Outlines Major 2026 Milestones as Cash Reserves Remain Robust and Clinical Data Builds Momentum

Market Chameleon (Fri, 27-Feb 11:52 AM)

Relay Therapeutics Sets Stage for Major Clinical Milestones in 2026 on Solid Financial Ground

Market Chameleon (Fri, 27-Feb 8:59 AM)

Relay Therapeutics Sets Financial Results Date as Phase 3 Trials on Zovegalisib Progress

Market Chameleon (Fri, 20-Feb 8:40 AM)

FDA Breakthrough Therapy Designation Positions Relay’s Zovegalisib as Potential Game-Changer for Advanced Breast Cancer

Market Chameleon (Tue, 3-Feb 7:38 AM)